Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FIRST: Lenalidomide + Dexamethasone vs MPT in Newly Diagnosed Multiple Myeloma
NCT00689936Phase 3Completed
- Sponsor
- Celgene Corporation
- Start
- Aug 2008
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 19
01
Overview
A Phase 3 trial of lenalidomide in multiple myeloma (MM), sponsored by Celgene Corporation. Started Aug 2008; status: completed.
02
Drugs
lenalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00689936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00689936.